Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
10/26/2000 | WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
10/26/2000 | WO2000028045A3 Human hydrolase proteins |
10/26/2000 | WO2000027815A3 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands |
10/26/2000 | WO2000020601A3 Polyketide synthase enzymes and recombinant dna constructs therefor |
10/26/2000 | WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
10/26/2000 | WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
10/26/2000 | DE19918325A1 Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives |
10/26/2000 | DE19918211A1 New 2-carbocyclyl-benzimidazole-carboxamide derivatives, are PARP inhibitors useful e.g. for treating neurodegenerative disease, epilepsy, ischemia, tumors, inflammation or diabetes |
10/26/2000 | CA2373359A1 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
10/26/2000 | CA2371976A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof |
10/26/2000 | CA2371972A1 Ent-steroids as selectively active estrogens |
10/26/2000 | CA2370884A1 Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease |
10/26/2000 | CA2370721A1 Neurotrophin potentiators |
10/26/2000 | CA2370684A1 Use of rubidium and in particular rubidium chloride as an antimanic agent and stabilizer for mood swings |
10/26/2000 | CA2370659A1 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof |
10/26/2000 | CA2370570A1 Dna encoding the human vanilloid receptor vr1 |
10/26/2000 | CA2370417A1 Substituted azoles |
10/26/2000 | CA2370129A1 Methods and compositions for modulating an immune response |
10/26/2000 | CA2370127A1 Novel method of treatment |
10/26/2000 | CA2370126A1 Estrogen receptor-.beta. ligands |
10/26/2000 | CA2369078A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk |
10/26/2000 | CA2368839A1 D-form polypeptide which induces immune tolerance and methods of use |
10/26/2000 | CA2368815A1 Novel synthesis and crystallization of piperazine ring-containing compounds |
10/26/2000 | CA2367356A1 New compounds, their preparation and use |
10/26/2000 | CA2365579A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
10/26/2000 | CA2365434A1 Angiogenic growth factors for treatment of peripheral neuropathy |
10/26/2000 | CA2364209A1 49 human secreted proteins |
10/26/2000 | CA2363689A1 Compounds useful as phosphotyrosine mimics |
10/25/2000 | EP1045908A2 Human urotensin ii |
10/25/2000 | EP1045850A1 Purine compounds having pde iv inhibitory activity and methods of synthesis |
10/25/2000 | EP1045849A1 Purine derivatives having phosphodiesterase iv inhibition activity |
10/25/2000 | EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity |
10/25/2000 | EP1045842A2 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines |
10/25/2000 | EP1045839A2 Novel amines as pharmaceutical agents |
10/25/2000 | EP1045834A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
10/25/2000 | EP1045833A1 2,3-substituted indole compounds as cox-2 inhibitors |
10/25/2000 | EP1045830A1 Alpha-aminoamide derivatives useful as analgesic agents |
10/25/2000 | EP1045826A1 Process for the preparation of isopropyl-methyl- 2-(3-n-propoxyphenoxy)ethyl]amine |
10/25/2000 | EP1045822A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments |
10/25/2000 | EP1045693A1 Aminophenoxyacetic acid derivatives as neuroprotectants |
10/25/2000 | EP1045690A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use |
10/25/2000 | EP0736039B1 Compounds with growth hormone releasing properties |
10/25/2000 | EP0720601B1 Gastrin and cck receptor ligands |
10/25/2000 | CN1271360A 1,3-dioxolo/4,5-Hl/2,3/benzodiazepine derivatives as AMPA/Kainate receptor inhibitors |
10/25/2000 | CN1271359A Novel compounds |
10/25/2000 | CN1271354A Compounds possessing neuronal activity |
10/25/2000 | CN1271353A Furansulfonic acid derivatives and pharmaceutical compositions containing the same |
10/25/2000 | CN1271347A 1,5-diphenylpypazole derivatives |
10/25/2000 | CN1271278A Treatment of conduct disorder |
10/25/2000 | CN1271251A 2-methyl-thieno-benzodiazepine formulation |
10/25/2000 | CN1271250A Polyamine treatment of neurological disorders |
10/25/2000 | CN1270959A 4-phenyl pyridine derivatives |
10/25/2000 | CN1057760C Amino acid substituted benzoylguanidines, process for their preparation, their use and medicament containing them |
10/25/2000 | CN1057676C Medicine for encephalatrophy and preparing method |
10/24/2000 | US6136974 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments |
10/24/2000 | US6136864 Denaturants for sympathomimetic amine salts |
10/24/2000 | US6136862 Intravenously administering an organic acid, ester, or salt thereof |
10/24/2000 | US6136861 Bicyclo[2.2.1]heptanes and related compounds |
10/24/2000 | US6136859 Mixture of selenmethionine, carotene, ascorbic acid, tocopherol, methionine and coenzyme q10 in a carrier |
10/24/2000 | US6136839 Using a sulfone or sulfoamide benzene compound |
10/24/2000 | US6136828 Endothelin receptor antagonists |
10/24/2000 | US6136825 Sulfonamide compounds having 5-HT receptor activity |
10/24/2000 | US6136824 1-piperidinyl-propan-2-derivatives and their use as therapeutic agents |
10/24/2000 | US6136819 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations |
10/24/2000 | US6136817 Opioid receptor antagonist compounds |
10/24/2000 | US6136812 Methods of administering AMPA receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
10/24/2000 | US6136805 Quinoxaline dione derivatives, their production and their use in medicaments |
10/24/2000 | US6136803 Cycloalkyl ether indanamine compounds |
10/24/2000 | US6136572 Recombinant KAT enzyme and process for its preparation |
10/24/2000 | US6136532 Methods for treating bipolar mood disorder associated with markers on chromosome 18q |
10/24/2000 | US6136332 Dermatological/pharmaceutical compositions comprising volatile oils/phenylated silicone oils |
10/24/2000 | CA2157247C Physical form of dihydro-2,3-benzodiazepine derivative |
10/24/2000 | CA2137445C Naphtalene derivates, process for their preparation and pharmaceutical compositions containing them |
10/24/2000 | CA2072283C Process for the preparation of diacetylrhein |
10/19/2000 | WO2000062068A1 Method to type prion proteins |
10/19/2000 | WO2000062067A1 Novel transduction molecules and methods for using same |
10/19/2000 | WO2000061779A1 49 human secreted proteins |
10/19/2000 | WO2000061774A2 Bone morphogenic proteins |
10/19/2000 | WO2000061755A2 Secreted human proteins |
10/19/2000 | WO2000061754A2 Human proteins and polynucleotides encoding them |
10/19/2000 | WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
10/19/2000 | WO2000061743A1 Apoptosis-associated gene |
10/19/2000 | WO2000061628A1 49 human secreted proteins |
10/19/2000 | WO2000061627A1 49 human secreted proteins |
10/19/2000 | WO2000061620A1 49 human secreted proteins |
10/19/2000 | WO2000061609A2 Prodrugs of thrombin inhibitors |
10/19/2000 | WO2000061608A2 Low-molecular inhibitors of complement proteases |
10/19/2000 | WO2000061606A1 Novel human voltage-gated potassium channel |
10/19/2000 | WO2000061604A2 Pharmaceutical compounds |
10/19/2000 | WO2000061596A1 50 human secreted proteins |
10/19/2000 | WO2000061587A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
10/19/2000 | WO2000061583A1 Xanthine derivatives and analogs as cell signaling inhibitors |
10/19/2000 | WO2000061576A1 Triarylimidazoles |
10/19/2000 | WO2000061571A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors |
10/19/2000 | WO2000061562A1 Neurotrophic substituted pyrimidines |
10/19/2000 | WO2000061558A1 Remedies for neuropathic pain |
10/19/2000 | WO2000061557A1 4-hydroxypiperidine derivatives having antiarrhythmic effect |
10/19/2000 | WO2000061554A1 1-amino ethylindole derivatives for the treatment of urinary incontinence |
10/19/2000 | WO2000061553A1 2-aminoethyl-indole derivatives, their preparation and therapeutic use |
10/19/2000 | WO2000061542A1 Caspase inhibitors and the use thereof |